As a virtual biotech, you’re in a challenging situation. You need a streamlined process and a diverse group of experts to help your skeleton crew reach the exit point. Whether it's a licensing deal or all the way to IND, you need to get there before your competition does. There can be a lot of pitfalls along the way.
Sidney, the founder of a virtual biotech with an idea for a drug to treat a rare neurological disorder, is faced with a situation that puts his funding at risk – can he convince his investors to continue their financing?
- Navigating the World of Preclinical CROs: Where to Start and How to Focus
- Designing a Novel Cancer Drug: From Hit ID to Candidate
- High-Throughput Screening: An Insider's Guide to Outsourcing